E A Perez Selected Research

E A Perez Research Topics

Disease

27	Breast Neoplasms (Breast Cancer) 10/2018 - 01/2000
10	Neoplasms (Cancer) 10/2018 - 07/2001
3	Cardiotoxicity 02/2012 - 09/2000
3	Neoplasm Metastasis (Metastasis) 11/2001 - 01/2000
2	Neutropenia 04/2006 - 08/2002
2	Osteoporosis 08/2001 - 08/2000
2	Vomiting 03/2000 - 01/2000
2	Nausea 03/2000 - 01/2000
1	Pathologic Complete Response 01/2016
1	Inflammatory Breast Neoplasms 01/2016
1	Hypertension (High Blood Pressure) 09/2014
1	Brain Neoplasms (Brain Tumor) 09/2008
1	Triple Negative Breast Neoplasms 09/2008
1	Endometrial Neoplasms (Endometrial Cancer) 09/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2007
1	Breast Cancer 3 11/2001
1	Disease Progression 08/2001
1	Bone Diseases (Bone Disease) 08/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2001
1	Heart Failure 01/2001
1	Metabolic Bone Diseases (Osteopenia) 08/2000
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2000

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 01/2016 - 02/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 09/2000
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2012 - 01/2000
5	Tamoxifen FDA LinkGeneric 07/2008 - 08/2000
4	Docetaxel (Taxotere)FDA Link 10/2018 - 08/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 09/2000
4	AnthracyclinesIBA 02/2012 - 01/2000
4	Estrogens (Estrogen)FDA Link 09/2008 - 08/2000
3	Letrozole (Femara)FDA LinkGeneric 02/2013 - 05/2005
3	Monoclonal AntibodiesIBA 11/2001 - 12/2000
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2018 - 03/2010
2	Hormones (Hormone)IBA 01/2016 - 09/2007
2	Aromatase InhibitorsIBA 10/2013 - 09/2007
2	Taxoids (Taxanes)IBA 02/2010 - 11/2001
2	ErbB Receptors (EGF Receptor)IBA 09/2008 - 11/2001
2	CholesterolIBA 09/2007 - 05/2005
2	taxaneIBA 02/2006 - 09/2000
2	Biological ProductsIBA 10/2001 - 07/2001
2	Trastuzumab (Herceptin)FDA Link 10/2001 - 12/2000
2	Cisplatin (Platino)FDA LinkGeneric 07/2001 - 01/2000
2	Estrogen ReceptorsIBA 07/2001 - 07/2001
2	Raloxifene Hydrochloride (Evista)FDA Link 11/2000 - 08/2000
1	130-nm albumin-bound paclitaxelIBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Hematoxylin (Haematoxylon)IBA 02/2015
1	Fulvestrant (Faslodex)FDA Link 10/2013
1	Capecitabine (Xeloda)FDA Link 02/2010
1	human ERBB2 proteinIBA 07/2008
1	exemestane (Aromasin)FDA Link 07/2008
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2006
1	Gemcitabine FDA Link 02/2006
1	Pemetrexed (MTA)FDA Link 02/2006
1	Triglycerides (Triacylglycerol)IBA 05/2005
1	Lipoprotein(a)IBA 05/2005
1	HDL LipoproteinsIBA 05/2005
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2005
1	LipidsIBA 05/2005
1	LDL CholesterolIBA 05/2005
1	HDL CholesterolIBA 05/2005
1	Tyrosine (L-Tyrosine)FDA Link 11/2001
1	Phosphotransferases (Kinase)IBA 11/2001
1	Diphosphonates (Bisphosphonates)IBA 08/2001
1	Protein Isoforms (Isoforms)IBA 07/2001
1	PlatinumIBA 07/2001
1	Progesterone FDA LinkGeneric 07/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2001
1	Toremifene (Fareston)FDA Link 07/2001
1	Protein Kinase C-epsilonIBA 07/2001
1	Epirubicin (Ellence)FDA LinkGeneric 09/2000
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2000
1	MineralsIBA 08/2000
1	Pharmaceutical PreparationsIBA 08/2000
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 08/2000
1	Serotonin (5 Hydroxytryptamine)IBA 03/2000
1	Phosphopyruvate Hydratase (Enolase)IBA 02/2000
1	AntiemeticsIBA 01/2000
1	Carboplatin (JM8)FDA LinkGeneric 01/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2000
1	Prochlorperazine (Compazine)FDA LinkGeneric 01/2000
1	Granisetron (Kytril)FDA LinkGeneric 01/2000

Therapy/Procedure

13	Therapeutics 02/2012 - 01/2000
10	Drug Therapy (Chemotherapy) 02/2010 - 01/2000
1	Neoadjuvant Therapy 01/2016
1	Duration of Therapy 09/2007
1	Drug Tapering 08/2002
1	Palliative Care (Palliative Therapy) 08/2001
1	Lymph Node Excision (Lymph Node Dissection) 07/2001
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2000
1	Chemoprevention 11/2000
1	Adjuvant Chemotherapy 01/2000